Michael Wong, MD
Interventional Pain Medicine · Bel Air, MDNPI 1538322870
Payments from drug & device makers
Across 787 payments — averaging $39.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$9K
- Abbott$4K
- Saluda Medical Americas, Inc.$3K
- MML US, Inc.$3K
- Nevro Corp.$1K
- Boston Scientific$1K
- plus $11K from 49 others
What the payments were for
- Speaking & faculty fees$7,42524%
- Travel & lodging$4,57815%
- Food & beverage$18,82361%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilretta$7,962
- ReActiv8$1,911
- Evoke SCS$1,495
- PROCLAIM$1,318
- HA MINUTEMAN G3-R$1,103
- OCTRODE$462
- Evoke$365
- Proclaim Family of SCS IPGs$300
- WaveWriter Alpha Prime 16$261
- Senza$228
- XLIF$165
- PAINTEQ$121
- Omnia$117
- INTELLIS ADAPTIVESTIM$105
- SPECTRA WAVEWRITER$102
- GENERAL PAIN MANAGEMENT$102
- StimQ Receiver Stimulator Kit Channel A US w Receiver$101
- StimQ Freedom 4A Receiver Kit Channel A US Receiver$101
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$101
- Freedom 4A Receiver Kit Channel A US w Receiver$101
How this compares
$30,832 in reported general payments places this provider in the 85th percentile of 56 interventional pain medicine providers in Maryland.
See all interventional pain medicine providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 171 | $2,129 |
| Naloxone Hcl | 26 | $1,599 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 43 | $742 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $737 |
| Oxycodone Hcl | 69 | $726 |
| Pregabalin | 50 | $628 |
| Methylprednisolone | 81 | $603 |
| Diclofenac Sodium | 18 | $411 |
| Cephalexin | 24 | $384 |
| Mupirocin | 62 | $384 |
| Tramadol Hcl | 43 | $165 |
| Tizanidine Hcl | 18 | $162 |
| Cyclobenzaprine Hcl | 16 | $111 |
| Methocarbamol | 11 | $90 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Bel Air
- Mark ColemanPikesville$1.3M
- Marc LoevRockville$318K
- Anish PatelFrederick$311K
- Aneesh SinglaSalisbury$167K
- Charles SimmonsAnnapolis$73K
- Ali El-MohandesHagerstown$57K
- Anna IrwinBethesda$30K
- Dontese NicholsonBaltimore$27K
- Rajesh JariNottingham$26K
- Kristoffer de LaraGermantown$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.